Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients.
Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, Bourgeois H, Senellart H, Trémolières P, Lizée T, Bennouna J, Urban T, El Khouri C, Charron A, Septans AL, Balavoine M, Landry S, Solal-Céligny P, Letellier C. Denis F, et al. Among authors: pourel n. J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx029. J Natl Cancer Inst. 2017. PMID: 28423407 Clinical Trial.
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A. Le Pechoux C, et al. Among authors: pourel n. Lancet Oncol. 2022 Jan;23(1):104-114. doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 15. Lancet Oncol. 2022. PMID: 34919827 Clinical Trial.
Recommendations for Post-Operative Radiotherapy after complete resection of Thymoma - a French DELPHI consensus initiative.
Basse C, Khalifa J, Thillays F, Le Pechoux C, Maury JM, Bonte PE, Coutte A, Pourel N, Bourbonne V, Pradier O, Belliere A, Le Tinier F, Deberne M, Tanguy R, Denis F, Padovani L, Zaccariotto A, Molina T, Chalabreysse L, Brioude G, Delatour B, Faivre JC, Cao K, Giraud P, Riet FG, Thureau S, Antoni D, Massabeau C, Keller A, Bonnet E, Lerouge D, Martin E, Girard N, Botticella A. Basse C, et al. Among authors: pourel n. J Thorac Oncol. 2024 Apr 10:S1556-0864(24)00161-8. doi: 10.1016/j.jtho.2024.04.003. Online ahead of print. J Thorac Oncol. 2024. PMID: 38608932
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06).
Locher C, Pourel N, Le Caer H, Berard H, Auliac JB, Monnet I, Descourt R, Vergnenègre A, Lafay IM, Greillier L, Chouaïd C. Locher C, et al. Among authors: pourel n. Lung Cancer. 2018 Jul;121:25-29. doi: 10.1016/j.lungcan.2018.04.017. Epub 2018 Apr 22. Lung Cancer. 2018. PMID: 29858022 Clinical Trial.
[A phase II study of weekly cisplatine plus oral vinorelbine with concomittant radiotherapy in non-dependent elderly patients with localized inoperable non small cell lung carcinoma (Essai GFPC 08-06, Raccosa)].
Locher C, Pourel N, Marin B, Vergnenègre A; et le GFPC. Locher C, et al. Among authors: pourel n. Rev Mal Respir. 2011 Jan;28(1):58-65. doi: 10.1016/j.rmr.2010.04.019. Epub 2011 Jan 11. Rev Mal Respir. 2011. PMID: 21277475 Clinical Trial. French.
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique].
Chauvet B, Mahé MA, Maingon P, Mazeron JJ, Mornex F; Société française de radiothérapie oncologique (SFRO); Chauvet B, Mahé MA, Maingon P, Mazeron JJ, Mornex F, Azria D, Barillot I, Chauvet B, Denis F, Lartigau É, Lipinski F, Maingon P, Mornex F, Ardiet JM, Bibault JE, Caudrelier V, Diaz O, de Crevoisier R, Dubray B, Estivalet S, Faivre JC, Fenoglietto P, Fumagalli I, Ferlay J, Giraud P, Hennequin C, Henoch H, Khodri M, Llacer C, Lagrange JL, Lorchel F, Mahé MA, Meyrieux C, de Martel C, Noël G, Oozeer R, Peiffert D, Pointreau Y, Pourel N, Pradier O, Rocher F, Thureau S, Eschwège F, Martin P, Parmentier G. Chauvet B, et al. Among authors: pourel n. Cancer Radiother. 2013 Aug;17 Suppl 1:S2-72. doi: 10.1016/j.canrad.2013.04.002. Epub 2013 Jul 31. Cancer Radiother. 2013. PMID: 23916854 French. No abstract available.
Radiotherapy for primary lung cancer.
Khalifa J, Lerouge D, Le Péchoux C, Pourel N, Darréon J, Mornex F, Giraud P. Khalifa J, et al. Among authors: pourel n. Cancer Radiother. 2022 Feb-Apr;26(1-2):231-243. doi: 10.1016/j.canrad.2021.11.005. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953709
Cisplatin-docetaxel induction plus concurrent 3-D conformal radiotherapy and weekly chemotherapy for locally advanced non-small cell lung cancer patients: a phase II trial.
Poudenx M, Bondiau PY, Chamorey E, Venissac N, Otto J, Pourel N, Castelnau O, Tessier E, De Surmont Salasc B, Berdah JF, Pop D, Michel C, Mouroux J. Poudenx M, et al. Among authors: pourel n. Oncology. 2012;83(6):321-8. doi: 10.1159/000342081. Epub 2012 Sep 13. Oncology. 2012. PMID: 22986621 Free article. Clinical Trial.
35 results